Feasibility of Telehealth Problem-Solving Therapy for Depressed Homebound Older Adults
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00903019|
Recruitment Status : Completed
First Posted : May 15, 2009
Last Update Posted : March 23, 2015
|Condition or disease||Intervention/treatment||Phase|
|Depression||Behavioral: Tele-Problem-Solving Therapy Behavioral: In-Person PST Behavioral: Attention control||Not Applicable|
Older people with disabilities who cannot leave their homes are at increased risk of depression or depressive symptoms. Short-term psychotherapy, without medications, has been found effective for treating this population of people. Problem-solving therapy (PST) is a brief, structured, cognitive-behavioral therapy that teaches people problem-solving and coping skills to deal with negative life events and daily problems. Previous research demonstrated that PST is an effective treatment for depression when delivered to older adults in their homes. The cost of service for these in-home visits, however, can be prohibitive for many older adults and social service providers. One way to extend treatment to more older adults is to deliver PST via teleconferencing (tele-PST). This study will test the feasibility and effectiveness of tele-PST in treating depression in homebound older adults.
This study will have two phases. Phase 1 will examine the feasibility of delivering treatment via teleconference. Participants in this phase will receive six weekly sessions of tele-PST and then complete a 2-week follow-up visit in which their depression, disability, and resourcefulness will be assessed. Logistical and procedural problems and acceptability of the treatment to participants will be used to guide modifications or adaptations made to tele-PST before conducting a larger, randomized trial in Phase 2.
Participation in Phase 2 will last 6 weeks, with follow-up visits lasting until 24 weeks after the conclusion of treatment. Participants will be randomly assigned to one of three groups: tele-PST, in-person PST, and attention control. Participants in the tele-PST group will receive six weekly sessions of PST via teleconference, and participants in the in-person PST group will receive six weekly sessions of PST from a study therapist in person. Both these groups will also receive six monthly maintenance calls from their study therapist after the completion of treatment. Participants in the attention group will receive six weekly phone calls followed by six monthly phone calls to monitor their health. All participants in Phase 2 will complete assessments at 2, 12, and 24 weeks following their treatment. These assessments will measure the adequacy of recruitment, enrollment, and retention strategies; the compliance rates and service delivery costs of tele-PST and in-person PST; and participants' depression, disability, and resourcefulness.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||158 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Health Services Research|
|Official Title:||Telehealth Problem-Solving Therapy for Depressed Homebound Older Adults|
|Study Start Date :||June 2009|
|Actual Primary Completion Date :||May 2013|
|Actual Study Completion Date :||May 2013|
Participants will receive problem-solving therapy (PST) delivered via teleconferencing (tele-PST).
Behavioral: Tele-Problem-Solving Therapy
Six sessions of tele-PST
Active Comparator: 2
Participants will receive problem-solving therapy (PST) delivered in-person.
Behavioral: In-Person PST
Six sessions of in person PST
Placebo Comparator: 3
Participants will receive monitoring phone calls.
Behavioral: Attention control
Six weekly telephone calls
- 24-item Hamilton Rating Scale for Depression (HAMD) [ Time Frame: Measured at 2, 12, and 24 weeks ]
- 12-item World Health Organization Disability Assessment Schedule (WHO-DAS-II) [ Time Frame: Measured at 2, 12, and 24 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00903019
|United States, Texas|
|University of Texas at Austin|
|Austin, Texas, United States, 78712-0358|
|Principal Investigator:||Namkee G. Choi, PhD||University of Texas at Austin|